Skip to main content
Year archive

Heidelberg Pharma AG — 2017 filings

All 72 regulatory filings released by Heidelberg Pharma AG (HPHA) in 2017, sourced directly from the official regulator.

72 Filings
2017 Period
2017 filings (72)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-11-28 German
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-11-28 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-11-28 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-11-28 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-11-27 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-27 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-27 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-27 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-27 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-27 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2017-11-23 English
Heidelberg Pharma AG raises approximately EUR 34.4 million from capital measure
Share Issue/Capital Change
2017-11-21 English
Heidelberg Pharma AG raises approximately EUR 34.4 million from capital measure
Share Issue/Capital Change
2017-11-21 English
Heidelberg Pharma AG announces subscription price for new shares and conversion price for convertible bonds from ongoing capital measure
Share Issue/Capital Change
2017-11-16 English
Heidelberg Pharma AG announces results from research collaboration with Heidelberg University and the DKFZ to be presented at ASH Annual Meeting
Regulatory Filings
2017-11-13 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
DGAP-DD: Heidelberg Pharma AG english
Director's Dealing
2017-11-10 English
Heidelberg Pharma AG plans capital measure to fund its ATAC development programs
Capital/Financing Update
2017-11-03 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-10-26 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-10-26 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-10-26 English
Heidelberg Pharma AG: Partner RedHill Announces Orphan Drug Designation for MESUPRON
Regulatory Filings
2017-10-26 English
WILEX AG successfully completes change of name to Heidelberg Pharma AG
Regulatory Filings
2017-10-19 English
Q3 statement / Q3 financial report 2016/2017
Earnings Release 9M 2017
2017-10-11 German
WILEX AG: Interim management statement for the first nine months of 2017
Earnings Release 9M 2017
2017-10-09 English
WILEX AG Announces Adjustment of Guidance
Regulatory Filings
2017-10-09 English
Datum:09.10.2017
Earnings Release 9M 2017
2017-10-09 German
WILEX AG: Subsidiary Heidelberg Pharma becomes Runner Up in the Category Best New Drug Developer at World ADC Award 2017
Regulatory Filings
2017-09-26 English
WILEX AG: Subsidiary Heidelberg Pharma to Present the Proprietary ATAC Technology Platform at the Annual World ADC Summit
Regulatory Filings
2017-09-20 English
WILEX AG reports first half 2017 results
Earnings Release H1 2017
2017-07-13 English
Half-yearly financial report 2016/2017
Interim / Quarterly Report H2 2017
2017-07-13 German
DGAP-DD: WILEX AG english
Director's Dealing
2017-07-07 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-07-06 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-07-06 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-07-06 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-07-06 English
WILEX AG: Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates
M&A Activity
2017-06-19 English
WILEX AG: Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates
M&A Activity
2017-06-19 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-06-19 German
Wilex AG: Bekanntmachung der Einberufung zur Hauptversammlung am 20.07.2017 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2017-06-08 German
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-06-07 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-06-02 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-06-02 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-05-31 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-05-23 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-05-22 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-05-18 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-05-18 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-05-18 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-05-18 English
DGAP-DD: WILEX AG english
Director's Dealing
2017-05-16 English
WILEX AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2017-05-16 English
WILEX AG successfully completes rights issue
Capital/Financing Update
2017-05-11 English
WILEX AG plans rights issue using authorised capital
Capital/Financing Update
2017-04-24 English
WILEX AG: Interim management statement on the first three months of 2017
Earnings Release Q1 2017
2017-04-12 English
Q1 statement / Q1 financial report 2016/2017
Interim / Quarterly Report Q1 2017
2017-04-12 German
WILEX announces financial figures for fiscal year 2016 and provides business update
Earnings Release FY 2016
2017-03-30 English
Annual financial report 2015/2016
Annual Report FY 2016
2017-03-30 German
Report Publication Announcement 2017
Report Publication Announcement
2017-03-16 English
WILEX AG Secures Financing Commitment from Its Main Shareholder dievini
Capital/Financing Update
2017-02-06 English
WILEX AG: Subsidiary Heidelberg Pharma Exercises Option on BCMA Antibodies of the Max Delbruck Center and Signs License Agreement
Regulatory Filings
2017-01-25 English
WILEX AG: WILEX signs antibody license agreement with Telix Pharmaceuticals Limited
M&A Activity
2017-01-16 English
WILEX AG: WILEX signs antibody license agreement with Telix Pharmaceuticals Limited
Regulatory Filings
2017-01-16 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements
2017-01-05 English